Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer
This study has been completed.
Sponsor:
Severance Hospital
Information provided by (Responsible Party):
Joohyuk Sohn, Severance Hospital
ClinicalTrials.gov Identifier:
NCT01208480
First received: September 23, 2010
Last updated: April 9, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |